European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives
Today, Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial fermentation announce a successful fundraising from private investors including Oskare Capital and Canopy Growth Cooperation (“Canopy Growth”) former CEO and founder Bruce Linton. Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange (TSX), included on a major stock index (S&P/TSX Composite Index) and to list on the New York Stock Exchange.
“We’re thrilled to have the backing of a pioneer in the cannabis industry” says Nethaji Gallage, CEO of Octarine. “Bruce’s expertise, network, and knowledge will be a valuable asset to us, and we look forward to accelerating our technology with his and our other private investors’ support”.
“Octarine is a promising young company with a platform technology that can accelerate several rapidly evolving sectors, including work on synthesizing rare and novel cannabinoids” says Bruce Linton. “I look forward to supporting the Company and seeing their technology utilized in the market”.
The new funds will be used to strengthen the Company’s existing intellectual property and to demonstrate the commercial scalability of its fermentation-based production platform. Octarineis currently raising a seed round expected to close in early 2020.
Octarine’s mission is harnessing synthetic biology to develop rare and functionally superior cannabinoids and psilocybin derivatives targeting the pharmaceutical industry to improve the health and well-being of people worldwide. Octarine has developed in-cell enzymatic platforms expanding the chemical diversity of cannabinoids and psychedelic tryptamine derivatives facilitating the production of superior molecules with improved pharmacokinetic properties.
For more information visit www.octarinebio.com
About Bruce Linton
Mr. Linton is the founder and former CEO of Canopy Growth and co-founder of Tweed Marijuana Incorporated. Under Mr. Linton's leadership, Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange. Mr. Linton held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp., and part of the establishing team at CrossKeys Systems Corporation ("CrossKeys"). He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AMAZENTIS23.1.2020 21:58:10 CET | Press release
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos
MA-LIONBRIDGE23.1.2020 19:02:07 CET | Press release
Lionbridge Names Corinne Saunders as Managing Director, EMEA
CA-PATIENT-SAFETY23.1.2020 18:36:07 CET | Press release
President Bill Clinton to Keynote 2020 World Patient Safety, Science & Technology Summit
COVANTIS-INITIATIVE23.1.2020 16:02:13 CET | Press release
Covantis initiative announces technology partner - ConsenSys
PATHOQUEST23.1.2020 14:02:09 CET | Press release
PathoQuest’s Paris-based Facility Obtains GLP Certificate for the Company’s Biologics Genomic Quality Control Testing Service
NY-MOODY’S23.1.2020 13:03:04 CET | Press release
Moody’s Acquires RDC, a Leader in Risk and Compliance Intelligence, Data and Software
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom